Compositions and methods for targeting type 1 interferon producing cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9758585
APP PUB NO 20150147322A1
SERIAL NO

14617882

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor α (IL-3Rα) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSL LIMITEDMELBOURNE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Busfield, Samantha Brunswick, AU 4 14
Maraskovsky, Eugene Kew, AU 31 363
Nash, Andrew Kew, AU 31 232
Panousis, Con Bundoora, AU 41 151
Vairo, Gino Luigi Northcote, AU 17 69
Wilson, Nick Brighton East, AU 23 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00